Calamos Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,957
Closed -$1.29M 1016
2023
Q4
$1.29M Buy
+5,957
New +$1.02M 0.01% 643
2021
Q1
Sell
-2,349
Closed -$600K 948
2020
Q4
$600K Sell
2,349
-1,770
-43% -$439K ﹤0.01% 708
2020
Q3
$975K Sell
4,119
-45
-1% -$9.48K 0.01% 653
2020
Q2
$809K Sell
4,164
-1,235
-23% -$236K 0.01% 651
2020
Q1
$894K Sell
5,399
-6,555
-55% -$1.2M 0.01% 604
2019
Q4
$2.05M Sell
11,954
-4,945
-29% -$824K 0.01% 607
2019
Q3
$2.79M Buy
16,899
+3,010
+22% +$423K 0.02% 589
2019
Q2
$1.66M Buy
+13,889
New +$1.42M 0.01% 624
2015
Q4
Sell
-30,510
Closed -$791K 682
2015
Q3
$791K Sell
30,510
-200,901
-87% -$6.09M 0.01% 557
2015
Q2
$7.17M Sell
231,411
-634,854
-73% -$18.7M 0.04% 325
2015
Q1
$28.9M Buy
866,265
+135,098
+18% +$4.56M 0.18% 163
2014
Q4
$33.7M Sell
731,167
-97,208
-12% -$4.16M 0.22% 123
2014
Q3
$30.5M Buy
828,375
+239,953
+41% +$8.76M 0.2% 135
2014
Q2
$23.3M Sell
588,422
-1,524
-0.3% -$58.6K 0.15% 168
2014
Q1
$28M Sell
589,946
-100,557
-15% -$4.45M 0.18% 154
2013
Q4
$25.6M Sell
690,503
-33,198
-5% -$1.23M 0.16% 159
2013
Q3
$26.2M Sell
723,701
-65,620
-8% -$2.2M 0.16% 149
2013
Q2
$24.8M Buy
+789,321
New +$22.4M 0.16% 151

Other funds holding PODD

Calamos Advisors's PODD Position: Q1 2024 in Review

Calamos Advisors sold out of Insulet (PODD) in Q1 2024, closing a stake of 5,957 shares — an estimated $1.29M sold.

Calamos Advisors first reported a position in PODD in Q2 2013 and held it in 18 quarters. The position peaked at $33.7M in Q4 2014. 563 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

  • Calamos Advisors reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
  • Calamos Advisors sold 5,957 Insulet shares in Q1 2024, an estimated $1.29M.
  • Calamos Advisors first reported a position in Insulet in Q2 2013 and held it in 18 quarters.
  • Calamos Advisors's Insulet position peaked at $33.7M in Q4 2014.
  • 563 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on Calamos Advisors's 13F filing for Q1 2024, filed 8 May 2024.